Journal article icon

Journal article

Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy

Abstract:
BackgroundRadiotherapy increases survival in patients with glioblastoma. However, the prescribed dose is limited by unwanted side effects on normal tissue. Previous experimental studies have shown that FLASH radiotherapy (FLASH-RT) can reduce these side effects. Still, it is important to establish an equal anti-tumor efficacy comparing FLASH-RT to conventional radiotherapy (CONV-RT).MethodsFully immunocompetent Fischer 344 rats with the GFP-positive NS1 intracranial glioblastoma model were irradiated with CONV-RT or FLASH-RT in one fraction of 20 Gy, 25 Gy or 30 Gy. Animals were monitored for survival and acute dermal side effects. The brains were harvested upon euthanasia and tumors were examined post mortem.ResultsSurvival was significantly increased in animals irradiated with CONV-RT and FLASH-RT at 20 Gy and 25 Gy compared to control animals. The longest survival was reached in animals irradiated with FLASH-RT and CONV-RT at 25 Gy. Irradiation at 30 Gy did not lead to increased survival, despite smaller tumors. Tumor size correlated inversely with irradiation dose, both in animals treated with CONV-RT and FLASH-RT. Acute dermal side effects were mild, but only a small proportion of the animals were alive for evaluation of those side effects.ConclusionThe dose response was similar for CONV-RT and FLASH-RT in the present model. Tumor size upon the time of euthanasia correlated inversely with the irradiation dose
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fonc.2023.1309174

Authors

More by this author
Role:
Author
ORCID:
0000-0002-1587-7951
More by this author
Role:
Author
ORCID:
0009-0009-1331-4483
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-0300-5790


More from this funder
Funder identifier:
10.13039/501100002794
Grant:
19 0146 Pj
More from this funder
Funder identifier:
10.13039/501100009780
More from this funder
Funder identifier:
10.13039/501100004635
More from this funder
Funder identifier:
10.13039/501100003173


Publisher:
Frontiers Media
Journal:
Frontiers in Oncology More from this journal
Volume:
13
Pages:
1309174-1309174
Article number:
1309174
Publication date:
2024-01-16
DOI:
EISSN:
2234-943X
ISSN:
2234-943X


Language:
English
Keywords:
Pubs id:
1620358
Local pid:
pubs:1620358
Source identifiers:
W4390917389
Deposit date:
2026-06-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP